Fluor Corp NT 10-Q, filed Nov 10, 2020
Fluor Corp (FLR)
|
UNITED STATES FORM 12b-25
NOTIFICATION OF LATE FILING |
| (Check one): | o Form 10-K | ¨ Form 20-F | ¨ Form 11-K | x Form 10-Q | ¨ Form 10-D | ||
| ¨ Form N-CEN | ¨ Form N-CSR | ||||||
| For Period Ended: | September 30, 2020 | ||||||
| ¨ Transition Report on Form 10-K | |||||||
| ¨ Transition Report on Form 20-F | |||||||
| ¨ Transition Report on Form 11-K | |||||||
| ¨ Transition Report on Form 10-Q | |||||||
| For the Transition Period Ended: | |||||||
| Read Instructions (on back page) Before Preparing Form. Please Print or Type. Nothing in this form shall be construed to imply that the Commission has verified any information contained herein. |
If the notification relates to a portion of the filing checked above, identify the Item(s) to which the notification relates:
PART I — REGISTRANT INFORMATION
| Fluor Corporation |
| Full Name of Registrant |
| Not Applicable |
| Former Name if Applicable |
| 6700 Las Colinas Blvd. |
| Address of Principal Executive Office (Street and Number) |
| Irving, Texas 75039 |
| City, State and Zip Code |
PART II — RULES 12b-25(b) AND (c)
If the subject report could not be filed without unreasonable effort or expense and the registrant seeks relief pursuant to Rule 12b-25(b), the following should be completed. (Check box if appropriate)
| (a) | The reason described in reasonable detail in Part III of this form could not be eliminated without unreasonable effort or expense | |
| o | (b) | The subject annual report, semi-annual report, transition report on Form 10-K, Form 20-F, Form 11-K, Form N-CEN or Form N-CSR, or portion thereof, will be filed on or before the fifteenth calendar day following the prescribed due date; or the subject quarterly report or transition report on Form 10-Q or subject distribution report on Form 10-D, or portion thereof, will be filed on or before the fifth calendar day following the prescribed due date; and |
| (c) | The accountant’s statement or other exhibit required by Rule 12b-25(c) has been attached if applicable. |
PART III — NARRATIVE
State below in reasonable detail why Forms 10-K, 20-F, 11-K, 10-Q, 10-D, N-SAR, N-CEN, or the transition report or portion thereof, could not be filed within the prescribed time period.
Fluor Corporation (“Fluor” or the “Company”) has determined that it is unable to file its Quarterly Report on Form 10-Q for the quarter ended September 30, 2020 (the “Q3 Form 10-Q”) within the prescribed period without unreasonable effort or expense. The Company has not yet filed its Form 10-Q for the quarter ended June 30, 2020 (the “Q2 Form 10-Q”) and does not anticipate being able to file the Q3 Form 10-Q until after the filing of the Q2 Form 10-Q. While there are no assurances as to timing, the Company expects to file the Q3 Form 10-Q before December 31, 2020.
PART IV — OTHER INFORMATION
| (1) | Name and telephone number of person to contact in regard to this notification | ||||
| Joseph L. Brennan | 469 | 398-7200 | |||
| (Name) | (Area Code) | (Telephone Number) | |||
| (2) | Have all other periodic reports required under Section 13 or 15(d) of the Securities Exchange Act of 1934 or Section 30 of the Investment Company Act of 1940 during the preceding 12 months or for such shorter period that the registrant was required to file such report(s) been filed? If answer is no, identify report(s). | ||||
| ¨ Yes x No | |||||
| Form 10-Q for the quarter ended June 30, 2020. | |||||
| (3) | Is it anticipated that any significant change in results of operations from the corresponding period for the last fiscal year will be reflected by the earnings statements to be included in the subject report or portion thereof? | ||||
| ¨ Yes x No | |||||
| If so, attach an explanation of the anticipated change, both narratively and quantitatively, and, if appropriate, state the reasons why a reasonable estimate of the results cannot be made. | |||||
| For the third quarter of 2019, the Company reported a net loss attributable to Fluor of $783 million (as restated), or $5.58 per diluted share, reflecting a non-cash charge of $546 million related to establishing a valuation allowance against net deferred-tax assets, a non-cash impairment charge of $290 million related to the COOEC-Fluor joint venture fabrication yard, Stork, and the Sacyr-Fluor joint venture in Spain, and $44 million for restructuring activities. Until the Q2 Form 10-Q and the Q3 Form 10-Q are filed, the quarters ended June 30, 2020 and September 30, 2020 remain open. As a result, while the Company does not anticipate that the current fiscal year results will include charges of the magnitude reflected in the restated financial results for the quarter ended September 30, 2019, the Company is not currently able to anticipate whether, upon reporting of the financial information for the 2020 second and third quarters, there will be any significant change in results of operations for the period ending September 30, 2020 from the corresponding period for the last fiscal year. | |||||
|
Cautionary Note Regarding Forward-Looking Statements
This Form 12b-25 contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, including, without limitation, Fluor’s expectations as to the filing of the Q2 Form 10-Q and Q3 Form 10-Q.
These forward-looking statements involve risks and uncertainties, and actual results could vary materially from these forward-looking statements. Factors that may cause future results to differ materially from management’s current expectations include, among other things, the severity and duration of the COVID-19 pandemic and actions by governments, businesses and individuals in response to the pandemic, including the duration and severity of economic disruptions, and the risk that the completion and filing of the Q2 Form 10-Q and Q3 Form 10-Q will take longer than expected. Fluor disclaims any obligation to update information contained in these forward-looking statements whether as a result of new information, future events, or otherwise. | |||||
Fluor Corporation
(Name of Registrant as Specified in Charter)
has caused this notification to be signed on its behalf by the undersigned hereunto duly authorized.
| Date | November 10, 2020 | By | /s/ John R. Reynolds, Chief Legal Officer |
INSTRUCTION: The form may be signed by an executive officer of the registrant or by any other duly authorized representative. The name and title of the person signing the form shall be typed or printed beneath the signature. If the statement is signed on behalf of the registrant by an authorized representative (other than an executive officer), evidence of the representative’s authority to sign on behalf of the registrant shall be filed with the form.
| ATTENTION | ||
| Intentional misstatements or omissions of fact constitute Federal Criminal Violations (See 18 U.S.C. 1001). | ||